Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 2004

View Archived Issues

Eisai assumes distribution responsibilities for Aciphex

Kyorin Pharmaceutical to tie up with ActivX Bioscience

BioPort signs contract to supply anthrax vaccine

Dyax and Baxter to collaborate in MIF antibody research

Innovative Companies files patent for method to stabilize levothyroxine

KaloBios and Celscia Therapeutics close merger

Morphotek and NCI sign agreement to develop antibodies for the treatment of various cancers

Amgen claims two series of calcium channel modulators for bone and PTH disorders

JT team presents MTP inhibitors devoid of hepatic side effects

New etonogestrel esters and their use presented by Akzo Nobel scientists

Novel factor Xa inhibitors prepared and tested at Boehringer Ingelheim

New adenosine A3 ligands jointly reported by Solvay and ArQule

Lilly claims new opioid antagonists with utility in obesity and related disorders

Novel protein kinase inhibitors for cancer and neurological disorders

Phase Ib trial evaluates WX-UK1 in head and neck cancer patients

Phase II trial design agreed for InKine's new generation purgative product

Phase I/II HGTV43 gene construct study commences

Pivotal Fibrillex study cleared to continue by DSMB

Axcan submits sNDA for 1g mesalamine suppository

Zyprexa approved for maintenance in bipolar disorder treatment

Remoxy advances into phase I

New expanded indication for Lamictal

Chiron HIV vaccine enters phase I trial

Procleix Ultrio Assay receives European CE Mark

Phase I inhaled doripenem trial commences enrollment

Improved survival found with Provenge(R) in patients with advanced prostate cancer

Significant improvements induced by renzapride in IBS

Dalbavancin reported more effective than vancomycin against catheter-related bloodstream infections

Evidence of antifungal activity found for Thymus essential oils

Topical imiquimod found safe and effective in squamous cell carcinoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...